.jpg)
Bio
Manel Esteller (Sant Boi de Llobregat, Barcelona, Catalonia, Spain, 1968) graduated in Medicine from the Universidad de Barcelona in 1992, where he also obtained his Ph.D. degree…
Researcher Links
Publications by Type
Loading publications…
The last 5 uploaded publications
Figure S8 from ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms
Alberto J. Arribas, Sara Napoli, Luciano Cascione, Laura Barnabei, Giulio Sartori, Eleonora Cannas, Eugenio Gaudio, Chiara Tarantelli, Afua A. Mensah, Filippo Spriano, Antonella Zucchetto, Francesca Maria Rossi, Andrea Rinaldi, Manuel Castro de Moura, Sandra Jovic, Roberta Bordone Pittau, Anastasios Stathis, Georg Stüssi, Valter Gattei, Jennifer R. Brown, Manel Esteller, Emanuele Zucca, Davide Rossi, Francesco Bertoni (2025). Figure S8 from ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms. , DOI: https://doi.org/10.1158/1535-7163.28547989.
Preprint73 days agoFigure S17 from ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms
Alberto J. Arribas, Sara Napoli, Luciano Cascione, Laura Barnabei, Giulio Sartori, Eleonora Cannas, Eugenio Gaudio, Chiara Tarantelli, Afua A. Mensah, Filippo Spriano, Antonella Zucchetto, Francesca Maria Rossi, Andrea Rinaldi, Manuel Castro de Moura, Sandra Jovic, Roberta Bordone Pittau, Anastasios Stathis, Georg Stüssi, Valter Gattei, Jennifer R. Brown, Manel Esteller, Emanuele Zucca, Davide Rossi, Francesco Bertoni (2025). Figure S17 from ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms. , DOI: https://doi.org/10.1158/1535-7163.28548016.
Preprint73 days agoAbstract 6160: Design and preclinical evaluation of a first-in-class covalent reversible inhibitor of IRAK4 with immunomodulatory properties and selective anti-lymphoma effect
Gema Gorjón-de-Pablo, Núria Profitós-Pelejà, M. H. Jacobs, Aitor Gonzalez-Herrero, Jeronimo Parra, Elisabetta Mereu, P. Escobar Cifuentes, Melissa Orphali, Jordi Teixidó, Manel Esteller, José I. Borrell, Roger Estrada‐Tejedor, Gaël Roué (2025). Abstract 6160: Design and preclinical evaluation of a first-in-class covalent reversible inhibitor of IRAK4 with immunomodulatory properties and selective anti-lymphoma effect. , 85(8_Supplement_1), DOI: https://doi.org/10.1158/1538-7445.am2025-6160.
Article73 days agoFigure S7 from ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms
Alberto J. Arribas, Sara Napoli, Luciano Cascione, Laura Barnabei, Giulio Sartori, Eleonora Cannas, Eugenio Gaudio, Chiara Tarantelli, Afua A. Mensah, Filippo Spriano, Antonella Zucchetto, Francesca Maria Rossi, Andrea Rinaldi, Manuel Castro de Moura, Sandra Jovic, Roberta Bordone Pittau, Anastasios Stathis, Georg Stüssi, Valter Gattei, Jennifer R. Brown, Manel Esteller, Emanuele Zucca, Davide Rossi, Francesco Bertoni (2025). Figure S7 from ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms. , DOI: https://doi.org/10.1158/1535-7163.28547992.
Preprint73 days agoAn Integrated Neuromuscular Training Intervention Applied in Primary School Induces Epigenetic Modifications in Disease‐Related Genes: A Genome‐Wide <scp>DNA</scp> Methylation Study
Fidanka Vasileva, Raquel Font‐Lladó, Víctor López‐Ros, Jordi Barretina, Aleix Noguera‐Castells, Manel Esteller, Abel López‐Bermejo, Anna Prats‐Puig (2025). An Integrated Neuromuscular Training Intervention Applied in Primary School Induces Epigenetic Modifications in Disease‐Related Genes: A Genome‐Wide <scp>DNA</scp> Methylation Study. , 35(1), DOI: https://doi.org/10.1111/sms.70012.
Article73 days ago